[Autonomic diabetic neuropathy].
Diabetic autonomic neuropathy is rarely symptomatic but very frequent at a subclinical stage. Symptoms may be gastrointestinal, urinary, genital or cardiac. Sudoral, vasomotor or pupillary symptoms may also occur. Standardized cardiovascular tests are used to investigate parasympathetic and sympathetic nervous control. Because of their easy feasibility and good reproducibility they might be performed in the largest part of the diabetic population. These tests also strongly suggest that cardiac autonomic neuropathy is of poor prognosis, even when it is subclinical. Most treatments are symptomatic, but optimized diabetes control and administration of aldose reductase inhibitors are rational therapeutic measures, although their long-term effectiveness remains to be demonstrated.
Service d'Endocrinologie, Diabétologie, Nutrition, Hôpital Jean-Verdier, Bondy.
P
P
Valensi
D003929:Diabetic Neuropathies / Q000150:complications*; D007172:Erectile Dysfunction / Q000209:etiology; D004935:Esophageal Diseases / Q000188:drug therapy / Q000209:etiology*; D005128:Eye Diseases / Q000209:etiology; D006331:Heart Diseases / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D011379:Prognosis; D013272:Stomach Diseases / Q000188:drug therapy / Q000209:etiology*; D013543:Sweat Gland Diseases / Q000209:etiology; D001745:Urinary Bladder Diseases / Q000188:drug therapy / Q000209:etiology
La neuropathie autonome diabétique.